Drug Pipeline

Guselkumab Dose 1 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
3
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
2
Phase 2/3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05197049 A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely… Crohn Disease Active, Not Recruiting
NCT05528510 A Study of Guselkumab Therapy in Participants With Moderately to Severely Active… Colitis, Ulcerative Active, Not Recruiting
Phase 2/3
NCT03466411 A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to… Crohn's Disease Active, Not Recruiting
Sponsors Running Guselkumab Dose 1 Trials
Janssen Research & Development, LLC (3)
Disease Areas
Crohn's Disease (2)
Get alerts when Guselkumab Dose 1 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free